SUSTAINED-RELEASE MICROPARTICLE-BASED ANTIREJECTION THERAPY THROUGH ENHANCEMENT OF REGULATORY T CELLS (SMARTER) PLATFORM FOR VCA IMMUNOMODULATION
$854,983FY2021Defense Health AgencyDOD
Wake Forest University Health Sciences, Winston-Salem NC
Wake Forest University Health Sciences, Winston-Salem NC